The parameters included were sex, hepatic encephalopathy, CKD, SBP, CART or ascites drainage, alubumin, alanine aminotransferase, hemoglobin A1c, BUN, creatinie, AFP, DCP, CTP score, and treatment with PPI/H2 blockers, and kanamycin/rifaximin (Table 2). This evidence concerns the gene GPT and chronic kidney disease.